Tuyac, Yvianna Reign R.
HRN: 21-26-60 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/23/2023
CEFUROXIME 750MG (VIAL)
02/23/2023
03/01/2023
IV
240mg
Q8Hrs
PCAP-C
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: PneumoniaBloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes